
Indoco Remedies Limited has informed the Exchange regarding a press release dated Jun 06, 2024, titled "Indoco Remedies receives tentative ANDA approval from USFDA forCanagliflozin and Metformin Hydrochloride Tablets".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated Jun 06, 2024, titled "Indoco Remedies receives tentative ANDA approval from USFDA forCanagliflozin and Metformin Hydrochloride Tablets".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies